Showing results (1271-1280 of 1,511) with videos related to

Sort By:
Pageof 152
Cancer Medicine|March 2, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew L Laccetti, Benjamin Garmezy, Lianchun Xiao, et al.
JCO Precision Oncology|March 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite InstabilityMohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2011
Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association studyJane C Figueiredo, Juan Pablo Lewinger, Chi Song, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinomaMohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Journal of the American College of Cardiology|March 27, 2024
Dapagliflozin and Days of Full Health Lost in the DAPA-HF TrialToru Kondo, Ulrik M Mogensen, Atefeh Talebi, et al.
International Journal of Cancer|October 10, 2020
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Daniela Mariosa, et al.
Brain : a Journal of Neurology|September 2, 2008
Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international seriesT E F Webb, M Poulter, J Beck, et al.
Cancer|February 8, 2017
The American Cancer Society's Cancer Prevention Study 3 (CPS-3): Recruitment, study design, and baseline characteristicsAlpa V Patel, Eric J Jacobs, Daniela M Dudas, et al.
ESC Heart Failure|May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and designJaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Cancer Medicine|January 20, 2025
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary TractMohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
Pageof 152